White cells, lymphoid disease and transfusion
The white cells and what their numbers mean, the causes and consequences of neutropenia, the leukaemias, lymphomas and myeloma and the emergencies they cause, the pathology of the immunosuppressed patient, and blood components with the mechanisms of transfusion reactions and massive transfusion.
By the end of this page you should be able to
- Describe the white cell lineages and interpret a raised or low count.
- Describe the causes of neutropenia and the pathology of neutropenic sepsis.
- Classify the leukaemias and lymphomas and describe their pathology and complications.
- Describe the pathology of myeloma and of the oncological emergencies.
- Describe the blood components and the mechanism of each transfusion reaction.
- Explain the pathophysiology of massive transfusion.
White cells and what the count means
- Neutrophils are the first responders to bacterial infection and tissue injury; they live only hours to a day or two in the tissues and have a large marrow reserve. Neutrophilia occurs with bacterial infection, inflammation, tissue necrosis, corticosteroids (which also demarginate cells), adrenaline, smoking, pregnancy and myeloproliferative disease. A left shift with band forms, toxic granulation and Dohle bodies suggests marrow release under pressure; a leukaemoid reaction can mimic leukaemia.
- Lymphocytes: B cells make antibody, T cells kill infected cells and regulate, natural killer cells act without prior sensitisation. Lymphocytosis suggests viral infection (especially Epstein-Barr with atypical mononuclear cells), pertussis, toxoplasmosis and chronic lymphocytic leukaemia; lymphopenia occurs in corticosteroid use, severe illness, human immunodeficiency virus infection and after chemotherapy or radiotherapy.
- Eosinophils rise with parasites (tissue-invasive rather than luminal), allergy and asthma, drug reactions, vasculitis (eosinophilic granulomatosis), adrenal insufficiency and some malignancies. Basophils are few, and a persistent basophilia suggests myeloproliferative disease. Monocytes become tissue macrophages and antigen-presenting cells; monocytosis occurs in chronic infection such as tuberculosis, in recovery from marrow suppression and in myelomonocytic disease.
- Interpret the count against the clinical state: a normal white cell count does not exclude serious infection, especially in the very young, the very old, the immunosuppressed and in overwhelming sepsis, where the count may be low. The absolute neutrophil count, not the total white cell count, is what determines infection risk.
Neutropenia and the immunosuppressed patient
Neutropenia arises from reduced production (chemotherapy, radiotherapy, marrow infiltration, aplastic anaemia, B12 and folate deficiency, drugs such as clozapine, carbimazole, sulfasalazine and some antibiotics), increased destruction (immune, hypersplenism, sepsis) or redistribution. Risk rises steeply as the count falls and as the duration lengthens.
With few neutrophils, the inflammatory response is absent, which changes the pathology: there is little pus, few local signs, no consolidation on an early chest film, and fever may be the only sign. Infection comes from the patient's own flora crossing damaged mucosal barriers (chemotherapy-induced mucositis is a major portal), from the skin and from indwelling lines, with Gram-negative organisms, Gram-positive skin organisms, and, with prolonged neutropenia, fungi.
Other immune defects produce characteristic patterns, which is worth knowing because it predicts the organism: splenectomy or functional asplenia removes the ability to clear encapsulated organisms and opsonise with antibody, giving overwhelming pneumococcal, meningococcal and Haemophilus sepsis; T cell deficiency (advanced human immunodeficiency virus infection, transplant immunosuppression, long-term corticosteroids) predisposes to intracellular and opportunistic organisms including Pneumocystis, mycobacteria, cytomegalovirus, Toxoplasma and Cryptococcus; B cell and antibody deficiency gives recurrent encapsulated bacterial infection; complement deficiency gives recurrent neisserial infection; and barrier breach (lines, catheters, burns) gives skin and environmental organisms.
Leukaemias, lymphomas and myeloma
- Acute leukaemias are clonal proliferations of immature blasts that fill the marrow and crowd out normal haematopoiesis, so the presentation is of marrow failure: anaemia, bleeding from thrombocytopenia, and infection. Acute lymphoblastic leukaemia is the commonest childhood malignancy and may infiltrate the central nervous system and testis; acute myeloid leukaemia is largely a disease of older adults, and its promyelocytic variant characteristically causes disseminated intravascular coagulation. Very high blast counts cause leukostasis with hypoxia and confusion, and treatment can precipitate tumour lysis.
- Chronic myeloid leukaemia is a myeloproliferative disease with the BCR-ABL fusion from the Philadelphia translocation, producing a very high neutrophil count with all stages of maturation, splenomegaly and a risk of blast transformation.
- Chronic lymphocytic leukaemia is an accumulation of mature but incompetent B lymphocytes, giving lymphocytosis, lymphadenopathy, splenomegaly, hypogammaglobulinaemia with recurrent infection, and autoimmune haemolysis or thrombocytopenia.
- Lymphomas are solid tumours of lymphoid tissue. Hodgkin lymphoma has Reed-Sternberg cells, a bimodal age distribution, contiguous nodal spread and the classical B symptoms of fever, night sweats and weight loss. Non-Hodgkin lymphomas are a heterogeneous group, from indolent follicular disease to aggressive diffuse large B cell and Burkitt lymphoma, the last with a very high proliferation rate and consequent tumour lysis risk.
- Myeloma is a clonal plasma cell malignancy producing a monoclonal paraprotein. The classical features follow its biology: lytic bone lesions and hypercalcaemia from osteoclast activation, renal impairment from light chain nephrotoxicity, hypercalcaemia and dehydration, anaemia from marrow replacement, and infection from immune paresis. Pathological fracture and spinal cord compression are the emergencies, and hyperviscosity can occur with a very high paraprotein.
- Oncological emergencies to recognise: febrile neutropenia, spinal cord compression (new back pain in a patient with cancer, treated before weakness develops), superior vena cava obstruction, hypercalcaemia of malignancy, tumour lysis syndrome (hyperkalaemia, hyperphosphataemia, hyperuricaemia, hypocalcaemia and acute kidney injury), raised intracranial pressure from metastases, and hyperviscosity.
Blood components
- Red cells are stored at 2 to 6 degrees for several weeks. Storage changes matter: potassium and lactate accumulate, 2,3-diphosphoglycerate falls so the oxygen dissociation curve shifts left and offloading is briefly impaired, cells become less deformable, and microaggregates form. Emergency-release units are group O, with RhD-negative units reserved for girls and women of childbearing potential.
- Platelets are stored at room temperature with agitation, so they have the shortest shelf life and the highest risk of bacterial contamination.
- Fresh frozen plasma contains all the coagulation factors in a large volume; cryoprecipitate is the cold-insoluble fraction, rich in fibrinogen, factor VIII and von Willebrand factor, so it is the concentrated way to replace fibrinogen. Prothrombin complex concentrate contains the vitamin K-dependent factors in a small volume.
- Compatibility: ABO antigens are matched because preformed IgM antibodies against the missing antigens cause immediate intravascular haemolysis. RhD matters because exposure produces IgG antibodies that cross the placenta and cause haemolytic disease of the newborn, and that cause delayed haemolysis on re-exposure. A group and screen identifies the group and looks for atypical antibodies; crossmatching then tests the specific unit.
Transfusion reactions and massive transfusion
Group reactions by time of onset, because that is how they present.
Within minutes: acute haemolytic reaction (preformed IgM against ABO antigens, complement-mediated intravascular lysis, giving fever, loin pain, haemoglobinuria, disseminated intravascular coagulation, shock and acute kidney injury; usually a clerical or identification error), anaphylaxis (IgE mediated, or in IgA-deficient recipients with anti-IgA antibodies), and bacterial contamination with rapid septic shock.
Within hours: febrile non-haemolytic reaction (recipient antibodies against donor leucocytes, and cytokines accumulated during storage; reduced by leucodepletion), transfusion-associated circulatory overload (hydrostatic pulmonary oedema from volume, in the elderly and those with cardiac or renal disease), and transfusion-related acute lung injury (donor antibodies or bioactive lipids prime recipient neutrophils in the pulmonary circulation, causing a permeability pulmonary oedema with hypoxaemia and bilateral infiltrates but normal filling pressures). The last two look alike and are distinguished by the mechanism: volume and a raised filling pressure against permeability with normal filling pressure.
Days to weeks: delayed haemolytic reaction (a secondary IgG response to a minor red cell antigen, with a falling haemoglobin and jaundice a week or so later), post-transfusion purpura, and transfusion-associated graft versus host disease in the severely immunosuppressed, prevented by irradiating components. Longer term there is iron overload and a small residual risk of transmitted infection.
Massive transfusion has its own pathophysiology, driven by the stored product and by the underlying shock: dilutional coagulopathy and thrombocytopenia, hypocalcaemia (citrate anticoagulant chelates ionised calcium, impairing coagulation and contractility), hyperkalaemia from stored cells (with later hypokalaemia as cells take potassium back up), metabolic acidosis then alkalosis as citrate is metabolised to bicarbonate, hypothermia from cold product, which both impairs enzymatic coagulation and shifts the dissociation curve, and the left-shifted curve of stored cells. The practical consequences are to warm everything, monitor and replace ionised calcium, use balanced ratios of components and give early fibrinogen, and treat the cause of bleeding rather than chasing numbers.
Making the answer flow
- Interpret counts in terms of the absolute neutrophil count and the clinical state, not the total white cell count.
- For the immunosuppressed patient, name the immune defect and then predict the organism; it reads as understanding rather than recall.
- Classify haematological malignancy by acute or chronic and myeloid or lymphoid, then give the pathology and the emergency each causes.
- Group transfusion reactions by onset, and separate circulatory overload from acute lung injury by mechanism.
Where marks are lost
- Taking a normal or low white cell count as reassurance in sepsis.
- Forgetting that neutropenic infection may have fever as its only sign.
- Saying stored red cells offload oxygen normally; 2,3-diphosphoglycerate falls during storage.
- Confusing circulatory overload with transfusion-related acute lung injury.
- Omitting ionised calcium and temperature from the problems of massive transfusion.
Where this meets surgical practice
- Lymph node excision biopsy, rather than fine needle aspiration, is often needed to diagnose lymphoma.
- Group and screen before elective surgery allows compatible blood to be issued quickly if needed.
Test yourself
Answer each one aloud or on paper before you open the model points; explaining the mechanism is what makes the MCQ options easy to judge.
- 1.
How do you interpret a raised white cell count?
Show answer
- Identify which lineage is raised; the differential is more informative than the total.
- Neutrophilia: bacterial infection, inflammation, necrosis, steroids, adrenaline, smoking, pregnancy, myeloproliferative disease.
- Left shift, toxic granulation and a leukaemoid reaction indicate marrow release under pressure.
- Lymphocytosis suggests viral infection or chronic lymphocytic leukaemia; eosinophilia suggests parasites, allergy, drugs or vasculitis.
- 2.
Why is the neutropenic patient with infection so dangerous?
Show answer
- Without neutrophils there is little inflammatory response: minimal pus, few localising signs, a normal early chest film.
- Fever may be the only sign, and deterioration can be rapid.
- Organisms come from the patient's own gut and skin flora through mucositis and lines; fungal risk rises with duration.
- Treatment is empirical broad-spectrum antibiotics immediately after cultures, without waiting for the count.
- 3.
Which infections would you expect in a splenectomised patient and why?
Show answer
- Encapsulated organisms: pneumococcus, meningococcus, Haemophilus influenzae, also Capnocytophaga after dog bites.
- The spleen clears opsonised encapsulated organisms and makes antibody against polysaccharide antigens.
- Risk of overwhelming post-splenectomy infection with rapid progression; also severe malaria and babesiosis.
- Prevention: vaccination, prophylactic antibiotics and a low threshold for early empirical treatment.
- 4.
How do acute leukaemias present and why?
Show answer
- Blasts fill the marrow and crowd out normal haematopoiesis, so marrow failure dominates.
- Anaemia, thrombocytopenic bleeding and infection; bone pain and organ infiltration.
- Hyperleukocytosis causes leukostasis with hypoxia and confusion; acute promyelocytic leukaemia causes disseminated intravascular coagulation.
- Treatment can precipitate tumour lysis syndrome.
- 5.
Describe the pathology of myeloma and its emergencies.
Show answer
- Clonal plasma cell proliferation with a monoclonal paraprotein.
- Osteoclast activation causing lytic lesions, fracture and hypercalcaemia.
- Renal failure from light chains, hypercalcaemia and dehydration; anaemia from marrow replacement; immune paresis with infection.
- Emergencies: pathological fracture, cord compression, hypercalcaemia, renal failure, hyperviscosity.
- 6.
What is tumour lysis syndrome?
Show answer
- Massive release of intracellular contents from rapidly dying tumour cells, spontaneously or after treatment.
- Hyperkalaemia, hyperphosphataemia, hyperuricaemia and secondary hypocalcaemia.
- Uric acid and calcium phosphate deposition in tubules cause acute kidney injury; arrhythmia from potassium and calcium changes.
- Highest risk in Burkitt lymphoma, acute leukaemias with high counts, and bulky chemosensitive disease.
- 7.
Describe the transfusion reactions and their mechanisms.
Show answer
- Minutes: acute haemolytic from preformed IgM against ABO, anaphylaxis including IgA deficiency, bacterial contamination.
- Hours: febrile non-haemolytic from leucocyte antibodies and cytokines; circulatory overload from volume; transfusion-related acute lung injury from neutrophil priming in the lung.
- Days to weeks: delayed haemolytic from IgG to minor antigens, post-transfusion purpura, graft versus host disease.
- Management principle: stop the transfusion, keep the line, support the patient and inform the blood bank.
- 8.
What are the metabolic consequences of massive transfusion?
Show answer
- Dilutional coagulopathy and thrombocytopenia; fibrinogen falls first.
- Hypocalcaemia from citrate chelation, impairing coagulation and contractility.
- Hyperkalaemia from stored cells, then hypokalaemia; acidosis then alkalosis as citrate is metabolised.
- Hypothermia impairing enzyme function and platelet behaviour; left-shifted dissociation curve of stored cells.
- Therefore: warm everything, replace ionised calcium, balanced component ratios, early fibrinogen, control the bleeding.
Practise this week
Week 13 in the other subjects
- Anatomy: Thoracic wall, pleura and lungs
- Physiology: Carbon dioxide transport and control of breathing
Not affiliated with the Royal Australasian College of Surgeons. Notes are a revision aid, not a substitute for the curriculum or for clinical guidelines.